Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dichlorobenzyl Alcohol
1. 1777-82-8
2. (2,4-dichlorophenyl)methanol
3. Dybenal
4. 2,4-dichlorobenzenemethanol
5. Rapidosept
6. Benzenemethanol, 2,4-dichloro-
7. Myacide Sp
8. Benzyl Alcohol, 2,4-dichloro-
9. Chebi:48220
10. Mfcd00004606
11. Nsc-15635
12. 1nkx3648j9
13. Ncgc00181337-01
14. Dsstox_cid_21362
15. Dsstox_rid_79699
16. Dsstox_gsid_41362
17. Cas-1777-82-8
18. 2,4-dichlorobenzylalcohol
19. Einecs 217-210-5
20. Nsc 15635
21. 2,4-dichlorobenzoyl Alcohol
22. Brn 1448652
23. Unii-1nkx3648j9
24. Ai3-20619
25. Schembl41323
26. Oxiconazole Related Compound D
27. Chembl3184437
28. Dtxsid9041362
29. (2,4-dichlorophenyl)methanol #
30. Dalc2-h_000039
31. Zinc157458
32. 2,4-dichlorobenzyl Alcohol, 99%
33. Dichlorobenzyl Alcohol [ii]
34. Dichlorobenzyl Alcohol [mi]
35. Nsc15635
36. Tox21_112796
37. Tox21_300895
38. Bdbm50498198
39. Dichlorobenzyl Alcohol [inci]
40. S6067
41. Stl480884
42. Dichlorobenzyl Alcohol [vandf]
43. Akos000248902
44. Dichlorobenzyl Alcohol [mart.]
45. Tox21_112796_1
46. Am81457
47. Db13269
48. Dichlorobenzyl Alcohol [who-dd]
49. Hy-w039454
50. Ps-5315
51. Ncgc00181337-02
52. Ncgc00181337-03
53. Ncgc00254799-01
54. Ac-10679
55. Sy015811
56. Db-015914
57. Cs-0097299
58. D1837
59. Ft-0610050
60. Ft-0674330
61. 77d828
62. Oxiconazole Related Compound D [usp-rs]
63. 2,4-dichlorobenzyl Alcohol [ep Monograph]
64. Q209202
65. Sr-01000944729
66. Sr-01000944729-1
67. W-107827
68. (2,4-dichlorophenyl)methanol;2,4-dichlorobenzyl Alcohol
69. Z111479786
70. 2,4-dichlorobenzyl Alcohol, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 177.02 g/mol |
---|---|
Molecular Formula | C7H6Cl2O |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 1 |
Exact Mass | 175.9795702 g/mol |
Monoisotopic Mass | 175.9795702 g/mol |
Topological Polar Surface Area | 20.2 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 108 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Dichlorobenzyl alcohol in combination with [DB13908] is available in over-the-counter products used for symptomatic relief of acute sore throat and postoperative sore throat.
In vitro studies with the combination of dichlorobenzyl alcohol and amylmetacresol have shown a virucidal against a number of viruses associated with the common cold which is observed by a reduction in the viral load. In clinical trials, administration of dichlorobenzyl alcohol lozenges has been shown to generate a reduced throat soreness and to provide pain relief and relief from difficulty in swallowing 5 minutes after administration. This effect can last for even 2 hours. The relief effect was shown to reach a steady-state after 45 minutes.
R - Respiratory system
R02 - Throat preparations
R02A - Throat preparations
R02AA - Antiseptics
R02AA03 - Dichlorobenzyl alcohol
Absorption
Dichlorobenzyl alcohol is released almost immediately from its formulation and reaches peak concentration after 3-4 minutes. The concentration in saliva after 120 minutes represents about 50% of the administered dose.
Route of Elimination
In preclinical trials, dermal administration of dichlorobenzyl alcohol results in renal elimination of 90% of the administered dose. After metabolism, dichlorobenzyl alcohol is excreted in the urine.
Volume of Distribution
This pharmacokinetic property has not been fully studied.
Clearance
This pharmacokinetic property has not been fully studied.
Dichlorobenzyl alcohol is metabolized in the liver to form hippuric acid.
This pharmacokinetic property has not been fully studied.
The use of dichlorobenzyl alcohol has been related to its antibacterial, antiviral and local anesthetic properties. The local anesthetic action of dichlorobenzyl alcohol is thought to be due to a reduced sodium channel blockade. The antiseptic mechanism of action of dichlorobenzyl alcohol is not fully understood but it is thought to be related to a denaturation of external proteins and rearrangement of the tertiary structure proteins.
Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.
Date of Issue : 2023-02-03
Valid Till : 2026-01-26
Written Confirmation Number : WC-0268
Address of the Firm :
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091n
Address of the Firm :
Certificate Number : CEP 2014-346 - Rev 01
Issue Date : 2024-12-18
Type : Chemical
Substance Number : 2410
Status : Valid
Date of Issue : 2022-09-07
Valid Till : 2025-07-02
Written Confirmation Number : WC-0248
Address of the Firm :
Date of Issue : 2024-09-05
Valid Till : 2027-03-31
Written Confirmation Number : WC-0498
Address of the Firm :
Certificate Number : CEP 2014-346 - Rev 01
Status : Valid
Issue Date : 2024-12-18
Type : Chemical
Substance Number : 2410
2,4 Dichloro Benzyl Alcohol BP/Ph. Eur
Date of Issue : 2024-09-05
Valid Till : 2027-03-31
Written Confirmation Number : WC-0498
Address of the Firm : E-13/14 & 15, MIDC Area, Ajanta Road, Jalgaon -425003 Taluka: Jalgaon, District ...
2,4-Dichlorobenzyl Alcohol BP/EP
Date of Issue : 2023-02-03
Valid Till : 2026-01-26
Written Confirmation Number : WC-0268
Address of the Firm : W-24,MIDC,Chemical Zone, Ambernath (West), Ambernath -421501, Dist-Thane, Mahara...
Date of Issue : 2022-09-07
Valid Till : 2025-07-02
Written Confirmation Number : WC-0248
Address of the Firm : Plot No. N-57, Anand Nagar, Additional M.I.D.C., Ambernath (East)-421506, Mahara...
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091n
Address of the Firm : P.O. Sejavta, Dist. Ratlam, Madhya Pradesh, India.
Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.
About the Company : Deccan Nutraceuticals Pvt. Ltd. (DNPL) is a group company of Alkaloids Corporation (India), was founded in 2001 and operates from a 22,000 sq. m. facility in Pune (India). Their co...
About the Company : Jinzhou Jiutai Pharmaceutical is a comprehensive pharmaceutical enterprise which has more than 60 years manufacturing history. It was set up in 1951. There are 5 workshops, one res...
About the Company : SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry. SLN Pharmachem is a...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Canada
Brand Name : ANTIBACTERIAL THROAT LOZENGES
Dosage Form : LOZENGE
Dosage Strength : 1.2MG
Packaging : 24
Approval Date :
Application Number : 2375567
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE
Dosage Form : LOZENGE
Dosage Strength : 1.2MG
Packaging : 8/10/12/16/24/32
Approval Date :
Application Number : 2382881
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : CEPACOL SENSATIONS
Dosage Form : LOZENGE
Dosage Strength : 1.2MG
Packaging :
Approval Date :
Application Number : 2382938
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : CEPACOL SENSATIONS SORE THROAT & COUGH
Dosage Form : LOZENGE
Dosage Strength : 1.2MG
Packaging :
Approval Date :
Application Number : 2388642
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : CEPACOL CHILDREN'S FRUITY STRAWBERRY
Dosage Form : LOZENGE
Dosage Strength : 1.2MG
Packaging : 8/10/12/16/24/32
Approval Date :
Application Number : 2404982
Regulatory Info :
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Strepsils Numbing (was Plus)
Dosage Form : LOZ
Dosage Strength : 40mg
Packaging : 16X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : India
2,4-Dichlorobenzyl alcohol; Amylmetacresol
Brand Name :
Dosage Form : Lozenge
Dosage Strength : 1.2MG; 0.6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
2,4-Dichlorobenzyl alcohol; Amylmetacresol
Dosage : Lozenge
Dosage Strength : 1.2MG; 0.6MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Swaas throat spray
Dosage Form : Throat Spray
Dosage Strength : 0.446%
Packaging : 50 to 200g
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 50 to 200g
Regulatory Info :
Dosage : Throat Spray
Dosage Strength : 0.446%
Brand Name : Swaas throat spray
Approval Date :
Application Number :
Registration Country : India
Market Place
Reply
13 Jun 2024
Reply
02 Jan 2023
Reply
08 Apr 2021
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
34
PharmaCompass offers a list of Dichlorobenzyl Alcohol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dichlorobenzyl Alcohol manufacturer or Dichlorobenzyl Alcohol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dichlorobenzyl Alcohol manufacturer or Dichlorobenzyl Alcohol supplier.
PharmaCompass also assists you with knowing the Dichlorobenzyl Alcohol API Price utilized in the formulation of products. Dichlorobenzyl Alcohol API Price is not always fixed or binding as the Dichlorobenzyl Alcohol Price is obtained through a variety of data sources. The Dichlorobenzyl Alcohol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dybenal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dybenal, including repackagers and relabelers. The FDA regulates Dybenal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dybenal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dybenal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dybenal supplier is an individual or a company that provides Dybenal active pharmaceutical ingredient (API) or Dybenal finished formulations upon request. The Dybenal suppliers may include Dybenal API manufacturers, exporters, distributors and traders.
click here to find a list of Dybenal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dybenal CEP of the European Pharmacopoeia monograph is often referred to as a Dybenal Certificate of Suitability (COS). The purpose of a Dybenal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dybenal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dybenal to their clients by showing that a Dybenal CEP has been issued for it. The manufacturer submits a Dybenal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dybenal CEP holder for the record. Additionally, the data presented in the Dybenal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dybenal DMF.
A Dybenal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dybenal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dybenal suppliers with CEP (COS) on PharmaCompass.
A Dybenal written confirmation (Dybenal WC) is an official document issued by a regulatory agency to a Dybenal manufacturer, verifying that the manufacturing facility of a Dybenal active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dybenal APIs or Dybenal finished pharmaceutical products to another nation, regulatory agencies frequently require a Dybenal WC (written confirmation) as part of the regulatory process.
click here to find a list of Dybenal suppliers with Written Confirmation (WC) on PharmaCompass.
Dybenal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dybenal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dybenal GMP manufacturer or Dybenal GMP API supplier for your needs.
A Dybenal CoA (Certificate of Analysis) is a formal document that attests to Dybenal's compliance with Dybenal specifications and serves as a tool for batch-level quality control.
Dybenal CoA mostly includes findings from lab analyses of a specific batch. For each Dybenal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dybenal may be tested according to a variety of international standards, such as European Pharmacopoeia (Dybenal EP), Dybenal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dybenal USP).